Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX)

2.74

+0.04 (1.48%)

Mar 17 - Close

Open
2.75
High
2.76
Low
2.71
Vol.
557.71K
Avg. Vol.
649.70K
Mkt Cap
151.15M
52Wk High
3.45
52Wk Low
0.12
Bid
0.24
Ask
0.25
P/E (Trailing)
11.41
Beta
0.56
Short %
1.70%
Div. Yield
—
Shares
55.98M

Company Profile

Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc.

750 Lexington Avenue

New York, NY 10022

United States - Map

Phone: (212) 531-5965

Fax: (212) 531-5961

Website: www.keryx.com

State of incorporation: Delaware

CEO: Ron Bentsur

Employees: 17

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Major

Is a biopharmaceutical company

A biopharmaceutical company, focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer.

Recent news for KERX

Members owning KERX also own

ANPI (20.00%), MVL (20.00%), DCTH (20.00%), TY (20.00%), ESLT (20.00%)

Member sentiment (?)    Neutral

««     MarketGuru Blog network     »»

Recent opinions on KERX

More opinions on KERX »

Top members owning KERX

* Average monthly return vs. S&P 500

- Advertisement -